Education
About Us
Working with TipRanks
Follow Us
ImageneBio (IMA)
NASDAQ:IMA
Total Valuation
ImageneBio has a market cap or net worth of $92.14M. The enterprise value is -$25.30M.
Market Cap$92.14M
Enterprise Value-$25.30M
Share Statistics
ImageneBio has 11,181,676 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,181,676
Owned by Insiders30.26%
Owned by Institutions37.24%
Financial Efficiency
ImageneBio’s return on equity (ROE) is -0.39 and return on invested capital (ROIC) is -42.77%.
Return on Equity (ROE)-0.39
Return on Assets (ROA)-0.35
Return on Invested Capital (ROIC)-42.77%
Return on Capital Employed (ROCE)-0.45
Revenue Per Employee350.00K
Profits Per Employee-4.92M
Employee Count10
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of ImageneBio is ―. ImageneBio’s PEG ratio is 0.52.
PE Ratio―
PS Ratio0.00
PB Ratio7.54
Price to Fair Value7.54
Price to FCF-20.64
Price to Operating Cash Flow-11.99
PEG Ratio0.52
Income Statement
In the last 12 months, ImageneBio had revenue of 3.50M and earned -36.57M in profits. Earnings per share was -1.02.
Revenue3.50M
Gross Profit3.50M
Operating Income-37.00M
Pretax Income-36.55M
Net Income-36.57M
EBITDA-35.47M
Earnings Per Share (EPS)-1.02
Cash Flow
In the last 12 months, operating cash flow was -46.89M and capital expenditures 0.00, giving a free cash flow of -46.89M billion.
Operating Cash Flow-46.89M
Free Cash Flow-46.89M
Free Cash Flow per Share-4.19
Dividends & Yields
ImageneBio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.85
52-Week Price Change-67.50%
50-Day Moving Average7.89
200-Day Moving Average12.99
Relative Strength Index (RSI)26.23
Average Volume (3m)69.52K
Important Dates
ImageneBio upcoming earnings date is Nov 12, 2025, Before Open (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 12, 2025
Ex-Dividend Date―
Financial Position
ImageneBio as a current ratio of 11.80, with Debt / Equity ratio of 4.90%
Current Ratio11.80
Quick Ratio11.80
Debt to Market Cap<0.01
Net Debt to EBITDA0.66
Interest Coverage Ratio0.00
Taxes
In the past 12 months, ImageneBio has paid 13.00K in taxes.
Income Tax13.00K
Effective Tax Rate>-0.01
Enterprise Valuation
ImageneBio EV to EBITDA ratio is -18.89, with an EV/FCF ratio of -19.95.
EV to Sales0.00
EV to EBITDA-18.89
EV to Free Cash Flow-19.95
EV to Operating Cash Flow-19.95
Balance Sheet
ImageneBio has $142.58M in cash and marketable securities with $10.96M in debt, giving a net cash position of $131.63M billion.
Cash & Marketable Securities$142.58M
Total Debt$10.96M
Net Cash$131.63M
Net Cash Per Share$11.77
Tangible Book Value Per Share$2.61
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for ImageneBio is $16.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$16.00
Price Target Upside157.65% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast-100.00%
EPS Growth Forecast45.48%